Safety and Activity of Lenalidomide in Combination with Obinutuzumab in Patients with Relapsed Indolent Non-Hodgkin Lymphoma: A Single Group, Open-Label, Phase 1/2 Trial

Ashwath Gurumurthi,Collin K. Chin,Lei Feng,Nathan H. Fowler,Paolo Strati,Fredrick B. Hagemeister,Luis E. Fayad,Jason R. Westin,Chizobam Obi,Janine Arafat,Ranjit Nair,Raphael E. Steiner,Sattva S. Neelapu,Christopher R. Flowers,Loretta J. Nastoupil

ECLINICALMEDICINE（2024）

Cited 0|Views4
No score
Key words
Follicular lymphoma,Lenalidomide,Obinutuzumab,Relapsed
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined